Tursi, A., Mocci, G., Lorenzetti, R., Allegretta, L., Brandimarte, G., Cassieri, C., Colucci, R., De Medici, A., Faggiani, R., Ferronato, A., Fiorella, S., Forti, G., Franceschi, M., Gallina, S., Giorgetti, G., Grasso, G., Larussa, T., Luzza, F., Penna, A., Pica, R., Piergallini, S., Porciello, S., Pranzo, G., Rodino', S., Scorza, S., Sebkova, L., Zampaletta, C., Elisei, W., & Picchio, M. (2021). long-term real-life efficacy and safety of infliximab and adalimumab in the treatment of inflammatory bowel diseases outpatients. European journal of gastroenterology & hepatology, 33(5), 670–679. http://access.bl.uk/ark:/81055/vdc_100145631921.0x000021